Surrey Heartlands

Joint Formulary & PAD

Raltegravir - POST-exposure prophylaxis of HIV-1 infection

You are here : Home > Formulary Search > Raltegravir - POST-exposure prophylaxis of HIV-1 infection

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
NHSE
R
Restrictions / Comments :
Important
For post-exposure prophylaxis (e.g. needlestick injuries), follow your organisation's protocols for referral and access. Use as recommended by BHIVA/BASHH guidelines.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Raltegravir
Indication :
POST-exposure prophylaxis of HIV-1 infection
Group Name :
Keywords :
needlestick, occupational health, HIV prophylaxis
Brand Names Include :
Isentress
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Raltegravir is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat POST-exposure prophylaxis of HIV-1 infection.

Committee Recommendations (1)

04 Sep 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

These drugs falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.

Clinicians / specialists within the Acute setting should only prescribe in line with their Trust formulary / pharmacy advice.

GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication